Pfizer spends $11.4B to buy Array BioPharma for its cancer drug chemistry

Pfizer spends $11.4B to buy Array BioPharma for its cancer drug chemistry

Pfizer spends $11.4 billion to buy Array BioPharma for its cancer drug chemistry

By MATTHEW HERPER

RUBY WALLAU FOR STAT

Targeted cancer drugs such as the ones that Array develops have been a major part of Pfizer’s research over the past decade.

READ MORE